Cinquegrani, Gloria
Spigoni, Valentina
Iannozzi, Nicolas Thomas
Parello, Vanessa
Bonadonna, Riccardo C. http://orcid.org/0000-0002-9809-1005
Dei Cas, Alessandra
Funding for this research was provided by:
University of Parma (“Bando straordinario di Ateneo per progetti di ricerca biomedica in ambito SARS-CoV-2 e COVID-19”, FIL, FIL)
Article History
Received: 18 October 2021
Accepted: 22 December 2021
First Online: 11 January 2022
Declarations
:
: This study protocol was approved by the Institutional Review Board (Comitato Etico Area Vasta Emilia Nord Prot. 44136) and carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: No informed consent was needed, as blood donor material was completely anonymized.
: RCB is a member of the following board/advisory panel: MSD, Eli Lilly Ltd, Amgen, Sanofi and invited speaker for Sanofi, MSD, Eli Lilly Ltd, Astra Zeneca, and Janssen. ADC is an invited speaker for MSD, Astra Zeneca, Sanofi, Eli Lilly Ltd, Doc Generici, and Servier. All other authors declare no competing interests.